STEPHEN B. EDGE, MD

Plain English
Researchers studied colon cancer in people from Appalachian Kentucky, a region with the highest rates of this cancer in the U.S., comparing it to patients from outside the region. They examined 99 tumors from local patients and found unique genetic traits, differences in gut bacteria, and variations in immune responses related to obesity. Their findings emphasize the need for targeted cancer research in specific populations, as understanding these unique characteristics could lead to better prevention and treatment strategies for colon cancer. Who this helps: This helps patients in Appalachian Kentucky and healthcare providers treating them.

Plain English
This study looked at the genetic factors linked to five thyroid diseases, including thyroid cancer and benign nodular goiter, by analyzing data from about 2.9 million genomes across 19 different biobanks. The researchers identified 883 genetic locations connected to these diseases, including 570 new ones, and found that certain genes were related to the risk of both benign and cancerous thyroid conditions. This research helps improve understanding of who might be at higher risk for aggressive thyroid cancer, allowing for better screening and management of patients. Who this helps: This helps patients at risk for thyroid diseases and their doctors by informing more personalized screening strategies.

Plain English
This study looked at how effective platinum chemotherapy is for men with a type of advanced prostate cancer, both for those with specific DNA repair mutations and those without these mutations. Researchers found that about 79% of the 24 patients analyzed had DNA repair alterations, but there were no significant differences in treatment response or survival rates based on these mutations. Specifically, 20% of patients with these mutations and 50% of those without achieved a significant decrease in prostate cancer markers after treatment. Who this helps: This research helps doctors better understand how to treat advanced prostate cancer in men, particularly regarding the use of platinum chemotherapy.

Plain English
This research paper focuses on expanding the way we measure "value" in cancer clinical trials. Researchers found that current trials mainly look at how effective and safe treatments are but often ignore important factors like how treatments affect quality of life, financial stress, and the time required from patients. By proposing a new framework that includes patient feedback and cost analysis, they aim to improve decision-making in cancer care. Who this helps: This helps patients and their doctors make better-informed decisions about cancer treatments.

Plain English
This study looked at the genetic factors that might make some people more likely to develop urinary tract cancer and how these factors could affect their response to certain cancer treatments. Researchers analyzed the DNA of 810 urinary tract cancer patients and found that about 16% had a specific genetic pathway related to the FOXP3 gene that made them more susceptible to the disease and affected their chances of responding well to immunotherapy. This means that understanding these genetic factors could lead to more personalized treatment options for patients, potentially improving their outcomes. Who this helps: This helps patients with urinary tract cancer and their doctors in choosing more effective treatment strategies.

Plain English
This study developed a new tool called qcCHIP that helps identify clonal hematopoiesis (CH) variants in blood samples. The researchers tested qcCHIP under various conditions, proving it works effectively regardless of the sample size or sequencing depth, and it allows for tailored data analysis based on specific patient groups. This is important because identifying CH can help predict health risks in cancer patients and others, improving patient care. Who this helps: Patients, especially those with cancer and other health conditions related to clonal hematopoiesis.

Plain English
This study looked at head and neck cancers to see how common certain gene changes, called gene fusions, are and their effects on the disease. Researchers found that 2.8% of the tumors in their analysis (which involved over 13,000 cases) carried oncogenic fusions, including 19 cases of FGFR3 fusions and 6 cases of EGFR fusions. These findings are important because they could lead to new targeted treatments for patients with these types of gene changes, potentially improving their outcomes. Who this helps: Patients with head and neck cancers that have specific gene fusions.

Plain English
This study looked at the genetics behind thyroid diseases, including thyroid cancer and benign thyroid conditions, by analyzing nearly 2.9 million genomes from various biobanks. Researchers found 235 known and 501 new genetic variants connected to these diseases and revealed that certain genes related to cell growth and repair play significant roles in thyroid cancer risk. This is important because it helps improve our understanding of who might be at higher risk for thyroid issues, paving the way for better diagnosis and treatment options. Who this helps: Patients with thyroid diseases and their doctors.

Plain English
This study examined how the average temperature in different regions affects the survival rates of nearly 270,500 breast cancer patients. The researchers found that patients living in warmer areas (average temperatures above 56.7°F) had a 7% better chance of surviving compared to those in colder areas (average temperatures below 48.5°F). This is important because it highlights how our environment might play a role in cancer outcomes, helping guide future treatments and support for patients based on where they live. Who this helps: Patients living with breast cancer.

Plain English
This study looked at a new treatment approach for patients with triple-negative breast cancer, a type of cancer that is harder to treat. Researchers combined standard chemotherapy with a special regimen designed to boost the immune system and enhance the effectiveness of the treatment. They found that 5 out of 9 patients, or about 56%, achieved a complete response where no cancer could be detected (pCR), which is similar to rates seen with other therapies, but without the harmful side effects. Who this helps: This benefits patients with triple-negative breast cancer who need more effective and safer treatment options.

Plain English
This research studied specific genetic changes in proteins called PD-L1 and PD-L2, which are important targets for cancer treatments known as immunotherapies. The team analyzed data from over 300,000 tumors and found 486 cases with these genetic variations. They discovered that more than half of the patients (52 out of 71) who had these variations responded well to PD-1 immunotherapy, indicating that these genetic changes could help identify which patients are likely to benefit from this type of treatment. Who this helps: Patients with certain types of cancer who may qualify for immunotherapy.

Plain English
This study looked at how living in warmer environments affects breast cancer patients’ chances of recovery and survival. It found that women in areas with average temperatures above 47.5°F had a 16% better chance of survival overall, and those in regions above 60.9°F were 9% more likely to completely respond to treatment. These findings are important because they suggest that climate can influence health outcomes for breast cancer patients, highlighting the need for further research on how to close the gap in care for those in colder areas. Who this helps: This helps breast cancer patients, especially those in colder climates.

Plain English
This study looked at how obesity affects the metabolism of gastrointestinal cancers differently in men and women. Researchers found that obese patients with adenocarcinomas showed significant changes in more than 4,000 genes related to metabolism and immune function. These changes, especially in how the body processes tryptophan, can lead to worse disease outcomes, and the patterns vary between genders. Who this helps: This benefits cancer patients and doctors by improving understanding of how obesity influences treatment responses and disease progression.

Plain English
This study examined how cancer care professionals prioritize various factors related to cancer treatment, such as patient quality of life, survival rates, and healthcare costs. They surveyed 514 members from a cancer research network and found that the most valued priority was patient quality of life, which received the highest ranking, followed by overall survival and access to care. This is important because it highlights a shift towards focusing on what matters most to patients when assessing cancer treatments, which can lead to better care strategies. Who this helps: Patients undergoing cancer treatment.

Plain English
This research paper focuses on burnout among female surgical trainees, highlighting that this group suffers from higher levels of stress and exhaustion compared to their male counterparts and other medical professionals. It suggests that while there have been attempts to address the issue with individual techniques like mentorship and self-care, a more holistic approach is needed to effectively combat burnout. This is important because a supportive environment can improve both the well-being of female surgeons and their performance in the medical field. Who this helps: This helps female surgical trainees and their mentors.

Plain English
This study looked at how effective CDK4/6 inhibitors—specifically palbociclib—are for treating metastatic hormone receptor-positive and HER2-negative breast cancer at Roswell Park Comprehensive Cancer Center. Among 222 patients treated between 2015 and 2021, those on letrozole had a median survival without disease progression of 27.6 months, while those on fulvestrant had 17.2 months. The findings show that while treatment effectiveness is similar to clinical trials, factors like recurrent disease and prior treatment can lead to shorter survival times without disease progression, which is important for understanding patient outcomes. Who this helps: This helps breast cancer patients and their doctors by providing important information about treatment effectiveness.

Plain English
This study looked at how two-spirit, lesbian, gay, bisexual, transgender, queer, and gender-variant (2SLGBTQ+) individuals use parks in Toronto and the challenges they face. Researchers found that these communities often encounter violence and discrimination in these spaces, which limits their access to the health and social benefits that greenspaces can offer. They highlight that this inequity is largely due to systemic barriers and suggest that improving park management can help create safer and more welcoming environments for everyone. Who this helps: This helps 2SLGBTQ+ communities and those involved in urban park planning.

Plain English
This study looked at why many people, especially older adults and minorities, don't join clinical trials in the U.S. Researchers surveyed patients who chose not to participate and found that the top reasons included misunderstandings about placebos, fears of being treated like a test subject, doubts about whether trial treatments work as well as standard ones, and worries about extra doctor visits or tests. Understanding these concerns is important because it can help health care providers create better ways to encourage participation, which can lead to more effective treatments. Who this helps: This helps patients considering clinical trial participation and the healthcare providers assisting them.

Plain English
This study looked at how doctors used genetic tests, called next generation sequencing (NGS), to decide on cancer treatments for patients. Among the 657 tests performed on 646 patients, doctors found that 14% identified the best treatment based on strong FDA-supported evidence, and they most often recommended targeted therapy (48%) when that strong evidence was present. This is important because it shows that having clear guidelines on genetic testing helps doctors make better treatment choices, which can lead to more effective care for cancer patients. Who this helps: Patients with advanced cancer.

Plain English
This study looked at how cancer cases are recorded and analyzed at the Lakeshore Cancer Center (LCC) in Lagos, Nigeria, over its first two years, from July 2014 to June 2016. They found 226 cancer cases, with breast cancer being the most common at 38%, followed by prostate cancer at 12%, and colorectal cancer at 8%. Most patients, about 85%, came in at advanced stages of cancer, highlighting the urgent need for better early detection and screening methods to improve treatment outcomes. Who this helps: This benefits patients by providing better data for earlier cancer detection and treatment.

Plain English
This study looked at how moving to rural areas in Canada affects the health of immigrants compared to those born in Canada. Researchers reviewed 25 articles and found that while there isn't much research connecting rural living to health outcomes, they did identify five key factors that influence the health of immigrants in these areas: social inclusion, culturally-appropriate services, gender, employment, and housing. Understanding these issues is important because it can help improve health services and support for immigrants who are settling outside major cities. Who this helps: This helps immigrants living in rural areas and the healthcare providers working with them.

Plain English
This research explored how different organizations work together to improve access to food for communities facing insecurity. Researchers interviewed stakeholders involved in a new coalition focused on food security and found that this collaboration led to better communication and more tailored support for individuals, as well as the establishment of a community food center that offered affordable fresh produce. However, the study also highlighted conflicts over resources and differing views on what dignified food access means. Who this helps: This benefits local communities, food companies, and organizations working in food assistance.

Plain English
This study looked at how oncologists used detailed genetic test results to choose targeted therapies for cancer patients at Roswell Park Comprehensive Cancer Center from June 2016 to June 2017. It found that only 28.4% of recommended targeted therapies were actually used based on these genetic tests, with the highest uptake (86%) among patients already receiving treatment. Additionally, most patients did not get targeted therapies until after their tests, with only 2.6% receiving them beforehand. Who this helps: This benefits cancer patients who may receive more personalized treatment options based on their genetic profiles.

Plain English
This study looked at women with ductal carcinoma in situ (DCIS) who underwent breast-conserving surgery and aimed to create a risk score that predicts the chance of cancer returning in the same breast. Researchers analyzed data from over 2,700 patients and found that the risk of recurrence varies: it was 9% for low-risk patients, 23% for those at intermediate risk, and 51% for high-risk patients over five years. This risk score helps patients and doctors make better-informed decisions about treatment by understanding individual risks. Who this helps: Patients with ductal carcinoma in situ (DCIS) and their doctors.

Plain English
This study compared two dry powder inhalers, FosterNEXThaler and SeretideDiskus, to see how effectively they deliver medication to patients. It found that FosterNEXThaler produces a higher number of small inhalable particles, with 74% of its particles being less than 5 micrometers, compared to SeretideDiskus, which had only 43%. This is important because it means FosterNEXThaler could provide a more effective treatment for respiratory conditions by allowing more medication to reach the lungs. Who this helps: This benefits patients with asthma and other respiratory conditions.

Plain English
This study looked at how women treated for ductal carcinoma in situ (DCIS) with breast-conserving surgery handle subsequent breast cancer events. Out of nearly 3,000 women, 200 (about 6.8%) experienced a second breast event within 4.2 years. The research found that women who had radiation therapy initially had a lower chance (6%) of experiencing a second event compared to those who didn't receive it (11%), but many went on to have more drastic treatments like mastectomy, with only 28% receiving antiestrogen therapy for the second event. Who this helps: This information helps patients and doctors understand treatment options and outcomes for women who may experience further breast issues after initial DCIS treatment.

Plain English
This study looked at how many breast cancer survivors received recommended annual mammograms and MRIs after their treatment. It found that the percentage of patients getting annual imaging dropped from 69.5% in the first year to 61.0% by the fourth year, and MRI use fell from 12.5% to 5.8%. Factors like being over 80, being younger than 50, being Black, having public insurance, and having more severe disease were linked to a lower likelihood of getting these screenings, highlighting the need for better outreach and support to ensure that vulnerable groups receive necessary follow-up care. Who this helps: This helps breast cancer survivors, especially those from underrepresented and at-risk groups.

Plain English
This study looked at how cattle farmers in England feel about a new system for trading cattle that considers the risk of bovine tuberculosis (bTB). Researchers interviewed 203 farmers and found that those in lower-risk areas were more supportive of the trading scheme compared to those in higher-risk regions. Farmers preferred third-party certifications from veterinarians or health agencies for trustworthiness, while self-certification by sellers was seen as less credible by buyers. This matters because understanding farmers' views can help create effective measures to control bTB and promote safer cattle trading. Who this helps: This helps cattle farmers and the agricultural industry by reducing the spread of disease.

Plain English
This research looked at how using two ingredients (called excipients) in dry powder inhalers (DPI) can improve these products for patients and doctors. The findings show that combining lactose and magnesium stearate in DPI products has successfully entered the market, making treatments more effective and diverse. This matters because it leads to better options for delivering medications to people with respiratory issues. Who this helps: Patients with respiratory conditions who use dry powder inhalers.

Plain English
This study examined ways to decrease the number of repeat surgeries (reoperations) that breast cancer patients undergo after their initial lumpectomy, while also ensuring that cosmetic results remain good. The conference participants, which included doctors and a patient representative, recommended several practices, including using advanced imaging techniques and better planning before and after surgery, to achieve these goals. By implementing these recommendations, the hope is to lower the reoperation rate, which varies significantly among patients. Who this helps: This helps breast cancer patients and their doctors.

Plain English
This study looked at how patients with ductal carcinoma in situ (DCIS) who had breast-conserving surgery dealt with recurrences of cancer later on. Researchers found that nearly half of the local recurrence cases turned out to be invasive cancer, and 40% of patients ended up needing a mastectomy at the time of recurrence. They also discovered that patients who received radiation during their initial treatment were less likely to have breast-conserving surgery again and more likely to face complications from their subsequent treatments. Who this helps: This research is beneficial for patients with DCIS and their doctors by providing insights into potential long-term effects of initial treatments.

Plain English
This study looked at how prepared women felt to make decisions about cancer screening and prevention after undergoing genetic testing for BRCA mutations. Out of 27 women surveyed, most reported feeling ready to make these decisions and had low levels of confusion or uncertainty about their choices. The results indicate that the way information is currently provided is effective for women at higher risk for hereditary breast and ovarian cancer. Who this helps: This helps women at risk for hereditary breast and ovarian cancer.

Plain English
This study looked at how refugee youth in Hamilton, Ontario understand health and what influences their well-being. Researchers interviewed 26 young people, finding that they see health as tied not just to typical factors like education and income, but to feeling a sense of belonging, having a positive self-identity, emotional health, and the ability to make choices about their lives. These insights highlight the importance of creating supportive environments that foster community and trust, which can help young refugees better manage the challenges they face. Who this helps: This benefits refugee youth and the organizations that support their health and integration.

Plain English
This study looked at a protein called Focal Adhesion Kinase (FAK) in breast cancer patients to see how it relates to their prognosis. The researchers found that high levels of FAK were linked to younger patients, lymphovascular invasion (which means cancer spreading through lymph or blood vessels), and a type of breast cancer known as triple-negative, showing that these patients might have a worse outcome. Specifically, patients with high FAK levels had a shorter overall survival and time without disease progression. Who this helps: This information benefits patients, especially those with triple-negative breast cancer, as it highlights a potential target for treatment.

Plain English
This study looked at how discrimination affects the health of immigrants and refugees in Canada, revealing that these populations face unique challenges that are not well understood. The researchers found that existing knowledge focuses mainly on health-care experiences and mental health, with women typically highlighted as more vulnerable, but there’s a lack of information about how men and youth experience discrimination. Understanding these issues is crucial for improving health services and support for newcomers. Who this helps: This research benefits immigrants, refugees, health care providers, and policymakers working to improve health equity.

Plain English
Researchers studied genetic variations related to breast cancer by analyzing data from over 55,000 individuals. They found 41 new specific genetic markers linked to an increased risk of developing breast cancer. This discovery is crucial as it may lead to better risk assessments and personalized prevention strategies for women at risk. Who this helps: This helps patients and doctors by providing more information for assessing breast cancer risk.

Plain English
This study looked at how disease-specific registries can collect and share medical data to improve patient care and research. Researchers found that over the past 17 years, more than $3 billion has been invested in these registries, but many are limited in their use due to strict rules about how the data can be used. The findings highlight the need for more flexible, cost-effective data systems that can support various medical studies and improve healthcare management. Who this helps: This helps doctors and healthcare systems to better track and manage patient care.

Plain English
This study looked at a new technology called OMNIDOSE® for filling dry powder inhalers with very small amounts of medication, specifically less than 10 mg. The researchers found that they could accurately fill powders at 1 mg and 5 mg, and when tested on a larger scale, the inhalers produced particles that were expected to deliver about 30% of the medication effectively. This is important because it could lead to better delivery of medications for respiratory conditions, making treatments more precise and effective. Who this helps: This helps patients with respiratory illnesses who use inhalers.

Plain English
This study looked at how specific genetic variations (called SNPs) in the FGFR2 gene are linked to breast cancer risk and how they interact with factors like smoking and alcohol use. Researchers examined 1,170 breast cancer patients and 2,115 healthy individuals, finding that the FGFR2 genetic variants increased breast cancer risk for former and current smokers, especially those with two copies of a specific variant, which had more than double the risk (2.11 times) compared to non-smokers without that genetic variant. Understanding these connections can help identify women at higher risk for breast cancer, especially those who smoke. Who this helps: This helps patients, especially women who smoke and are at risk for breast cancer.

Plain English
This study looked at the accuracy of hormone receptor tests for breast cancer by comparing results from initial needle biopsies (CNB) to those from final surgical biopsies (EB). Researchers found that while 80% of CNBs showed positive results for estrogen receptors (ER) and 67% for progesterone receptors (PR), the EB results were 81% for ER and 74% for PR, indicating a high overall agreement of about 93%. This matters because incorrect receptor status could lead to missing out on effective hormone therapies for patients, so repeating the tests on surgical samples is crucial. Who this helps: This helps breast cancer patients who may need hormone therapy.

Plain English
This study examined how to improve the agreement between two tests used to check for HER2, a protein linked to some breast cancers. Researchers looked at 106 cases and found that adjusting the categories for what counts as uncertain results (equivocal) could increase agreement of test results; for instance, only 13.3% of cases with low-level HER2 staining actually showed amplification, while a significant number (31.3%) of cases with moderate-level staining did not show it. Improving these testing methods is important because it can lead to more accurate diagnoses and better treatment decisions for patients. Who this helps: Patients with breast cancer and their doctors.

Plain English
This study looked at how well enhanced safety measures on chicken farms can reduce the spread of a harmful bacteria called Campylobacter during the harvesting of chickens. Researchers found that while these measures did lower the bacteria's presence in the environment, they did not stop the chickens from becoming infected. In fact, almost all samples collected showed contamination, especially from transport crates that weren't cleaned properly, leading to continued spread among chicken flocks. Who this helps: This information is important for farmers and food safety officials to improve practices and protect public health.

Plain English
This study looked at whether surgery to remove the primary tumor helps patients with stage IV breast cancer live longer. Researchers analyzed data from 609 patients and found that those who had surgery lived an average of 3.5 years, while those who did not have surgery lived about 3.4 years, showing no significant difference in survival rates. This matters because it challenges the idea that surgery might be beneficial for these patients, suggesting that other treatments may be more important. Who this helps: This helps patients with stage IV breast cancer by providing clearer guidance on treatment options.

Plain English
This study looked at how body weight, measured by body mass index (BMI), affects whether women with early-stage breast cancer receive adjuvant chemotherapy. It analyzed data from over 9,500 women, finding that factors like age and being non-Hispanic black were linked to lower chances of receiving chemotherapy, but weight did not seem to play a role. These findings suggest that there may be other reasons behind why some women do not get this important treatment, highlighting the need for more research into these disparities. Who this helps: This helps patients and healthcare providers by identifying barriers to treatment access.

Plain English
This study looked at how different types of lactose affect the delivery of medication through inhalers. It found that using lactose that can easily flow led to better medication doses; specifically, patients received between 24 to 49 micrograms of the drug budesonide. The findings are important because they help improve how inhalers work, ensuring patients receive the right amount of medication effectively. Who this helps: This helps patients using inhalers, especially those with respiratory conditions.

Plain English
This study looked at the risk of blood clots in women with early-stage breast cancer who were taking tamoxifen, a treatment for the disease, and how it relates to a common genetic mutation called Factor V Leiden (FVL). They found that 18.5% of women who had blood clots while on tamoxifen had the FVL mutation, compared to only 4.8% of women who did not have clots. This means that women with the FVL mutation are nearly five times more likely to develop blood clots when taking tamoxifen, highlighting the importance of genetic testing before starting this treatment. Who this helps: This helps patients undergoing tamoxifen treatment and their doctors in making better-informed treatment decisions.